Jazz Pharmaceuticals Plc (JAZZ)
168.94
-0.76
(-0.45%)
USD |
NASDAQ |
Dec 08, 16:00
169.92
+0.98
(+0.58%)
After-Hours: 06:24
Jazz Pharmaceuticals Shareholders Equity (Quarterly): 3.959B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zymeworks, Inc. | 320.06M |
| Alkermes Plc | 1.733B |
| Medtronic Plc | 48.65B |
| Avadel Pharmaceuticals Plc | 98.22M |
| Amarin Corp. Plc | 458.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.36B |
| Total Liabilities (Quarterly) | 7.397B |
| Debt to Equity Ratio | 1.371 |
| Current Ratio | 1.652 |
| Net Debt Paydown Yield | 0.91% |